Importantly, celastrol/2-DG combination exhibited markedly enhanced inhibition of tumor growth (Fig. 9d–f) and suppression of cell proliferation as reflected by the expression level of Ki67 (Fig. 9h), compared to each monotherapy. Here, MKI67 is linked to neoplasm.